Woodall v. Western Express, Inc.

District Court, D. New Mexico·Decided March 3, 2025·No. 1:23-cv-00862·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO ____________________

JIMMY WOODALL,

Plaintiff,

v. Case No. 1:23-cv-00862 LF-JMR

WESTERN EXPRESS, INC., and CURT MOELLER,

Defendants.

MEMORANDUM OPINION AND ORDER DENYING DAUBERT MOTIONS

This matter comes before the Court on Defendants’ Motion to Exclude the Opinions of Dr. Dillin (Doc. 137) and Defendants’ Motion to Exclude the Opinions of Craig Callewart, M.D. (Doc. 138). These two motions, filed pursuant to Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and Federal Rule of Evidence 702, seek to exclude Mr. Woodall’s treating physicians from testifying at trial at all. Doc. 137 at 1; Doc. 138 at 1. In the alternative, they seek to limit the scope of these physicians’ testimony to recounting the treatment they provided to Mr. Woodall. Doc. 153 at 4; Doc. 155 at 4. Mr. Woodall responded to both motions. Docs. 144, 145. The Court, having reviewed the parties’ submissions and the applicable law, finds that Defendants’ motions are not well-taken and therefore DENIES both motions for the reasons outlined below. BACKGROUND This case arises out of a vehicle collision which took place in July 2022 in Gallup, New Mexico. Doc. 43 at 2. In the complaint, Mr. Woodall alleges that he sustained “severe and disabling injuries” as a result of the collision. Id. He seeks medical expenses along with damages for physical and mental pain and suffering, physical impairment, loss of enjoyment of life, and lost wages. Id. at 6. Mr. Woodall has listed Dr. Linden Dillin and Dr. Craig Callewart as treating physicians. Doc. 144-1 at 4–5. Mr. Woodall intends to call Dr. Dillin to testify regarding his shoulder injuries, Doc. 137 at 1–2, and to call Dr. Callewart to testify regarding his neck and back injuries,

Doc. 138 at 1–2. Defendants seek to preclude testimony from these experts. Docs. 137, 138. ANALYSIS I. Disclosures and Reports Defendants first argue that Dr. Dillin and Dr. Callewart were not designated as expert witnesses and therefore should not be allowed to testify as experts. Doc. 137 at 4; Doc. 138 at 4. Mr. Woodall responds that he classified Dr. Dillin and Dr. Callewart as non-retained expert witnesses in his Eleventh Supplemental Initial/Expert Disclosure on July 24, 2024. Doc. 144 at 2; Doc. 145 at 2; see also Doc. 144-2 (Plaintiff’s Eleventh Supplemental Initial/Expert Disclosure). Federal Rule of Civil Procedure 26(a)(2) states that “a party must disclose . . . the

identity of any witness it may use at trial to present evidence under Federal Rule of Evidence 702, 703, or 705.” The applicable local rule, D.N.M.LR-26.3, affirms this obligation. Here, Mr. Woodall disclosed Drs. Dillin and Callewart as expert witnesses in his Eleventh Supplemental Initial/Expert Disclosure. Doc. 144-2. He therefore has satisfied the disclosure requirement. Defendants argue in their reply that because Drs. Dillin and Callewart are expected to testify regarding causation and future treatment, they were required to produce expert reports pursuant to Federal Rule of Civil Procedure 26(a)(2)(B). Doc. 153 at 1; Doc. 1571 at 1. The

1 Both Documents 155 and 157 are entitled “Defendants’ Reply in Support of Defendants’ Motion to Exclude the Opinions of Dr. Dillin.” The Court assumes that the later-filed document, Doc. 157, is the intended operative reply. motions to exclude did not raise this argument, and arguments raised for the first time in a reply brief are waived. In re: Motor Fuel Temperature Sales Pracs. Litig., 872 F.3d 1094, 1112 n.5 (10th Cir. 2017). Even if the motions had included this argument, the local rules quickly dispense with it: “[Expert] reports need not be provided as to hybrid fact/expert witnesses such as treating physicians.” D.N.M.LR-Civ. 26.3(b). Moreover, treating physicians may testify regarding

causation, prognosis, and/or future treatment under specified circumstances. See, e.g., Wilks v. BNSF Ry. Co., No. 18-cv-080-KEW, 2021 WL 1236780, at *2 (E.D. Okla. Mar. 31, 2021) (treating physician may testify regarding causation of injuries if determination of causation was integral to treatment or evident from treatment); George v. Metro. Prop. & Cas. Ins. Co., No. 18- cv-01663-PAB-SKC, 2020 WL 70424, at *6 (D. Colo. Jan. 2, 2020) (“Causation opinions formed as a result of the treating physician’s own treatment of the plaintiff, and relevant to the treatment that the physician provided, do not require an expert report.”); Adrean v. Lopez, No. 10-cv-0670- CVE-FHM, 2011 WL 6141121, at *3 (N.D. Okla. Dec. 9, 2011) (treating physician’s testimony may include opinions regarding “‘prognosis, the extent of present and future disability, and the

need for future medical treatment,’” so long as the opinions are based on the physician’s personal knowledge gained from the care and treatment of the plaintiff) (quoting Goeken v. Wal-Mart Stores, Inc., No. 99-cv-4191-SAC, 2001 WL 1159751, at *3 (D. Kan. Aug. 16, 2001)). II. Assistance to the Trier of Fact Next, Defendants argue that Drs. Dillin and Callewart will not provide testimony that assists the trier of fact because the physicians admit that they cannot opine as to the extent to which Defendants caused Mr. Woodall’s alleged injuries. Doc. 137 at 6; Doc. 138 at 6. Their arguments on this issue overlap in some respects with the arguments in their Motion for Partial Summary Judgment, Doc. 136, which the Court denied. See Doc. 165. There, Defendants argued that Mr. Woodall could not prove the extent of the aggravation to his injuries because Drs. Dillin and Callewart could not quantify the extent of aggravation to Mr. Woodall’s preexisting injuries; Defendants claimed that medical testimony was necessary for Mr. Woodall to prove aggravation. See Doc. 165 at 3. But medical testimony about the percentage of aggravation is not the sole method of proving aggravation; the plaintiff’s own comparative testimony is also an option. Id.

at 4–5. Here, Defendants argue that because Drs. Dillin and Callewart cannot testify as to the extent of causation or aggravation, their testimony is useless to the trier of fact. Doc. 137 at 6–7; Doc. 138 at 6–7. Again, testimony by the doctors to quantify the extent of aggravation to Mr. Woodall’s preexisting injuries is not required. See generally Doc. 165. Furthermore, quantifying the extent of aggravation is not the sole purpose that the doctors’ testimony may serve. Mr. Woodall points out that Drs. Dillin and Callewart both have “personal knowledge of the care, diagnosis, causation, past/future treatment, and costs of past/future treatment regarding [Mr.] Woodall’s injuries” and therefore will be of assistance to the trier of fact. Doc. 144 at 5; Doc. 145 at 5. Drs.

Dillin and Callewart examined and treated Mr. Woodall and can provide context and explanations for the tests they performed and the results of those tests. Doc. 144 at 6; Doc. 145 at 6. The Tenth Circuit has held that a court considering whether an expert will assist the trier of fact should consider “(1) whether the testimony is relevant; (2) whether it is within the juror’s common knowledge and experience; and (3) whether it will usurp the juror’s role of evaluating a witness’s credibility.” United States v.

Free access — add to your briefcase to read the full text and ask questions with AI

Woodall v. Western Express, Inc., (D.N.M. 2025).

Woodall v. Western Express, Inc. (Woodall v. Western Express, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Rodriguez-Felix
450 F.3d 1117 (Tenth Circuit, 2006)
United States v. Gutierrez De Lopez
761 F.3d 1123 (Tenth Circuit, 2014)
Wilson v. Circle K Stores, Inc.
872 F.3d 1094 (Tenth Circuit, 2017)